Sponsor Pipeline

Ji Dongmei Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07509099 Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC Squamous Cell Carcinoma of Head and Neck Not Yet Recruiting
Phase 2
NCT07464366 The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic… Salivary Gland Carcinomas Recruiting
Get alerts when Ji Dongmei's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free